Life Expectancy After Aortic Aneurysm Repair: What to Know

Most people who undergo planned aortic aneurysm repair survive for years afterward, and some reach a life expectancy close to what they would have had without the aneurysm. In one study of patients over 80 who had elective repair, survival was statistically indistinguishable from a sex- and age-matched general population.¹ That is the optimistic end of the spectrum, though. Survival after repair varies widely depending on whether the surgery was planned or performed as an emergency, the location of the aneurysm, the patient’s age and overall health, and even the hospital where the procedure takes place.

The Biggest Divider Is Whether the Aneurysm Ruptured

Nothing predicts post-repair survival more strongly than the circumstances of the operation. When an abdominal aortic aneurysm is caught early and repaired electively, roughly seven in ten patients are alive five years later. When the aneurysm has already ruptured and repair is performed as an emergency, that five-year survival drops to about four in ten.² The gap is visible at every time point. A binational registry covering nearly two decades of cases found that one-year survival after elective endovascular repair was around 93%, while one-year survival after repair of a ruptured aneurysm was about 67%.³

There is a useful way to think about these numbers. For people who survive the first 90 days after elective repair, the relative five-year survival, meaning survival compared with what you would expect for someone of the same age and sex without an aneurysm, was about 90%. Even after ruptured aneurysm repair, patients who made it through the first three months had a relative five-year survival near 87%.² In other words, the early perioperative period is where most of the mortality risk concentrates. If you survive the operation and the immediate recovery, the long-term picture is considerably brighter.

Open Repair Versus Endovascular Repair

For abdominal aortic aneurysms, there are two broad surgical approaches: traditional open surgery and endovascular aneurysm repair (EVAR), which threads a stent graft into the aorta through small incisions in the groin. EVAR dominates modern practice because it is less invasive and has shorter hospital stays. The trade-off between the two is not straightforward, and it depends heavily on the patient’s age.

In patients younger than 65, open repair appears to offer better long-term survival, with one large study finding that EVAR carried about a 39% higher long-term risk of death compared with open repair in that age group. In patients between 65 and 79, the two approaches produced similar long-term results. And in patients 80 and older, EVAR was associated with a meaningfully lower risk of death.⁴ A separate study focused specifically on people in their eighties found that while EVAR patients had higher one-year survival (about 93% versus 84% for open repair), the five-year survival rates converged, and overall mean life expectancy was the same at roughly six years regardless of technique.⁵

A Medicare-matched database analysis adds another dimension: after propensity score matching, patients who had open repair had lower rates of death, aneurysm rupture, and reintervention over the long term compared with EVAR patients.⁶ The emerging picture is that younger, healthier patients tend to do better with open repair in the long run, while older or frailer patients benefit from the gentler recovery that EVAR provides even if it brings a higher chance of needing follow-up procedures.

Thoracic Aortic Aneurysm Repair

Aneurysms of the thoracic aorta (the section running through the chest) are a different beast from those in the abdomen. Thoracic endovascular repair (TEVAR) has become common here too, and its short-term survival advantage over open surgery is well established. For ruptured thoracic aneurysms, perioperative mortality was nearly halved with TEVAR in a Medicare population study (about 28% versus 46% for open repair).⁷

Long-term survival after thoracic repair can be surprisingly good. In patients treated with TEVAR for type B aortic dissection, survival rates at one, five, and ten years were roughly 93%, 84%, and 74%.⁸ However, the long-term comparison with open surgery is more complicated. In the Medicare population, patients with intact thoracic aneurysms who received TEVAR actually had worse five-year survival than those who had open repair (about 62% versus 72%). The likely explanation is patient selection: sicker patients are steered toward the less invasive option, so the TEVAR group starts with worse baseline health.⁷ A systematic review of younger patients (under 65) with descending thoracic aneurysms found conflicting evidence on which approach wins over the long haul, though TEVAR consistently showed higher reintervention rates.⁹

What Actually Kills Patients After a Successful Repair

Here is something that surprises many people: the aneurysm itself is rarely what kills patients in the years after a successful repair. Heart disease and cancer account for the overwhelming majority of late deaths. In one large cohort tracking over 1,500 deaths after abdominal aortic aneurysm repair, ischemic heart disease caused about 18% and lung cancer about 13%, with chronic lung disease accounting for another 6%.¹⁰ A separate study found cardiovascular deaths (not related to the aneurysm) in about 35% of deceased patients and cancer-related deaths in 29%, with lung cancer again the most common type.¹¹

This pattern makes sense when you consider the risk profile of a typical aneurysm patient. The same factors that cause aneurysms, particularly smoking and atherosclerosis, also drive heart disease and lung cancer. In fact, research shows that the diameter of the aorta at the time of diagnosis is itself an independent marker of cardiovascular disease risk. Even after a successful repair, larger aneurysm size at baseline predicts higher cardiovascular mortality for years afterward.¹² The practical takeaway is that fixing the aneurysm eliminates one threat but does not erase the underlying vascular disease. Managing that broader risk profile is what actually extends life after repair.

Medications That Improve Long-Term Survival

Statin therapy stands out as one of the most consistent predictors of better outcomes after aneurysm repair. A meta-analysis pooling data from nearly 70,000 patients found that statin use was associated with a roughly 35% reduction in total mortality after abdominal aortic aneurysm repair.¹³ Interestingly, the benefit appears to be a long-term phenomenon rather than a perioperative one. One study found that statin use before surgery did not reduce 90-day mortality at all, but postoperative statin use was strongly linked to better long-term survival.¹⁴ High-intensity versus low-to-moderate-intensity statin therapy made no difference, suggesting that taking a statin at all mattered more than the dose.¹⁴

Blood pressure control is equally critical, especially for thoracic and dissection repairs. A 25-year follow-up of patients who had surgery for type A aortic dissection found that keeping systolic blood pressure below 120 mm Hg was associated with freedom from reoperation of about 92% at ten years, versus roughly 49% in patients whose systolic pressure stayed above 140 mm Hg. Being on a beta-blocker also made a large difference, with 86% freedom from reoperation at ten years compared with 57% without one.¹⁵ Uncontrolled hypertension stresses the repaired aorta and accelerates problems at other sites along the vessel.

Smoking and Its Outsized Impact

Given that smoking is the strongest modifiable risk factor for developing an aortic aneurysm in the first place, it should be no surprise that continued smoking after repair substantially worsens the outlook. In patients treated with TEVAR for uncomplicated type B dissection, smokers had a ten-year survival rate of about 74%, compared with roughly 87% for non-smokers. Smoking more than doubled the risk of death during follow-up.¹⁶ Quitting is one of the highest-impact things a patient can do after aortic surgery, both for the health of the repair itself and for reducing the heart disease and lung cancer risk that drive most late deaths.

Kidney Disease and Other Comorbidities

Chronic kidney disease has a graded, dose-response relationship with post-repair survival: the worse the kidney function, the worse the outcome. In a large study, patients on dialysis at the time of surgery had roughly a fourfold higher risk of death within one year compared with patients who had normal or mildly reduced kidney function, and this held true for both open and endovascular repair.¹⁷ Even moderately impaired kidney function (not requiring dialysis) carried meaningfully higher mortality.

Coronary artery disease is another frequent companion. In patients undergoing thoracic endovascular repair, those with known coronary artery disease had nearly double the unadjusted long-term mortality rate (about 32% versus 18%) compared with those without it. However, after adjusting for other health differences between the groups, the association weakened and was no longer statistically clear.¹⁸ That likely reflects the difficulty of separating the effect of coronary disease from the many other health problems it travels with. What is clear is that overall cardiovascular fitness matters more than any single diagnosis.

Endoleaks and the Need for Follow-Up Procedures

One of the main trade-offs of endovascular repair is the possibility of endoleaks, in which blood continues to flow into the aneurysm sac around or through the stent graft. Not all endoleaks are dangerous, but some require additional procedures. A study examining long-term outcomes found that patients whose initial EVAR showed no endoleak on completion imaging had an 83% chance of being free from reintervention at five years. For those with certain types of endoleaks, that number dropped as low as 36%.¹⁹

This is why ongoing surveillance imaging is a standard part of life after EVAR. Current practice involves periodic imaging to check for endoleaks, changes in aneurysm sac size, and graft integrity. One study found that patients selected for ultrasound-only surveillance (rather than CT scans) after the first postoperative year had lower rates of reintervention, rupture, and mortality. This likely reflects the fact that patients with stable, uncomplicated repairs are the ones shifted to ultrasound monitoring, rather than anything about the imaging modality itself.²⁰ The point is that surveillance adherence matters. Catching a developing endoleak early means it can be addressed before it becomes a life-threatening problem.

Quality of Life After Repair

Survival numbers do not tell you how you will feel. After elective endovascular repair in older patients, mental health scores tend to bounce back to baseline within about four to six weeks, while physical health takes roughly three months to recover.²¹ After that initial recovery window, quality-of-life scores generally hold steady at preoperative levels for one to three years.

The picture for thoracoabdominal aneurysm repair, a more extensive operation, is less rosy. A systematic review found that while there is an initial improvement in quality of life after surgery, patients often fail to reach their pre-surgical baseline even after seven years, with physical activity and functioning being the most affected domains. Postoperative complications such as spinal cord injury or cardiovascular events have a particularly harsh impact on long-term quality of life.²² For standard abdominal aneurysm repair, long-term survivors report somewhat lower quality-of-life scores than the general population, with differences in mobility, self-care, and usual activities.²³ It is hard to separate how much of this gap is due to the surgery itself versus the underlying health profile of the patient population.

Where You Have Surgery Matters

Hospital and surgeon experience are real variables in survival, particularly for open repair. In one large analysis, perioperative mortality for open repair ranged from about 6.4% at the lowest-volume surgeon practices to 3.8% at the highest-volume ones. Hospital volume showed a similar pattern. For endovascular repair, individual surgeon volume mattered less, but hospital volume still did: lower-volume hospitals had about 50% higher odds of perioperative death compared with the highest-volume centers.²⁴ For complex aortic root procedures, a similar volume-outcome relationship holds, with a steep mortality improvement up to about 30 to 40 cases per year, after which the curve flattens.²⁵

Sex Differences in Outcomes

Women represent a small fraction of aortic aneurysm repair patients, but their outcomes deserve specific attention. Women tend to present with smaller aneurysms and more challenging anatomy for stent grafts, including shorter and more angled landing zones. Despite this, five-year mortality after endovascular repair is comparable between women and well-matched men (about 34% versus 38%). Aneurysm-related mortality was actually lower in women. The catch is that women have a much higher rate of a specific complication: type IA endoleaks, where blood leaks around the top of the stent graft, occurred at roughly ten times the rate seen in men (10% versus 1% through five years).²⁶ This means women may need closer surveillance and are more likely to require secondary procedures, even if their overall survival is reassuring.

Socioeconomic Disparities

Your neighborhood and economic circumstances are linked to how well you fare after aortic repair, independent of the clinical variables. Patients living in more deprived areas had about a 43% higher risk of death after aortic dissection repair, and this disparity extended to 30-day mortality as well.²⁷ A separate study confirmed clear socioeconomic disparities in operation rates, how patients present (elective versus emergency), and outcomes after surgery.²⁸ Part of this likely reflects differences in access to screening, which determines whether an aneurysm is caught before rupture, and differences in access to high-volume surgical centers and post-operative follow-up care.

Marfan Syndrome and Connective Tissue Disorders

Patients with Marfan syndrome face a different situation than the typical aneurysm patient. The disease affects the connective tissue throughout the aorta, not just in one segment. A landmark study found that aortic aneurysm repair raised median survival in Marfan patients to about 61 years, a meaningful improvement over the 47-year median observed three decades earlier. However, more than half of patients required second surgeries to address subsequent aneurysms or dissections at other aortic sites.²⁹ Predictors of needing additional operations included having a dissection at the time of the first surgery, uncontrolled blood pressure after surgery, and a history of smoking. For Marfan patients, the first repair is often the beginning of lifelong aortic surveillance and management rather than a definitive fix.

Emerging Tools for Predicting Individual Risk

One of the frustrations with population-level survival statistics is that they tell you what happened to groups, not what will happen to you. Research is now exploring machine learning models that integrate clinical data, imaging measurements, nutritional markers, and immune function indicators to produce individualized survival estimates after EVAR. Early evidence suggests these models capture complex interactions among variables better than traditional statistical methods, which tend to assume simpler relationships among risk factors.³⁰ These tools are not yet part of routine clinical decision-making, but they signal a shift toward more personalized risk conversations between patients and their surgeons. A fenestrated EVAR study (involving custom-made stent grafts for complex anatomy) found that the observed median age of survival was about 84 years, compared with a population-based expectancy of roughly 87 years, and that age and overall health status at the time of surgery were the strongest predictors of how long patients lived afterward.³¹ The gap between observed and expected survival was modest, reinforcing the point that for well-selected patients, aortic repair gets you close to a normal lifespan.